Skip to main content
. Author manuscript; available in PMC: 2024 Sep 1.
Published in final edited form as: Am J Obstet Gynecol MFM. 2023 Jul 10;5(9):101086. doi: 10.1016/j.ajogmf.2023.101086

Table 4.

Results from adjusted regression models quantifying the association between treatment group and breastfeeding outcomes at the postpartum clinic visit.

Model Estimate 95% CI P
Ever Breastfed (n = 1444) Log-binomial 0.99 (aRR) 0.93 – 1.05 0.78
Current Breastfeeding at postpartum visit (n = 1124) Log-binomial 1.01 (aRR) 0.94 – 1.10 0.75
Total Weeks Breastfeeding (n = 1108) Cumulative Logit 0.87 (aOR) 0.68 – 1.12 0.30

CI, confidence interval; aRR, adjusted risk ratio; aOR, adjusted odds ratio.

All models compare active treatment group (receive antihypertensive medications with goal blood pressure of < 140/90 mm Hg) to control group (defer antihypertensive treatment until blood pressure ≥ 160/105 mm Hg) as a predictor for breastfeeding outcomes. All models adjusted for gestational age (at enrollment and delivery), body mass index, and discharged on antihypertensive medication.